Net profit of RPG Life Sciences rose 27.92% to Rs 13.24 crore in the quarter ended March 2024 as against Rs 10.35 crore during the previous quarter ended March 2023. Sales rose 7.17% to Rs 126.99 crore in the quarter ended March 2024 as against Rs 118.49 crore during the previous quarter ended March 2023.
For the full year,net profit rose 29.60% to Rs 87.66 crore in the year ended March 2024 as against Rs 67.64 crore during the previous year ended March 2023. Sales rose 13.50% to Rs 582.05 crore in the year ended March 2024 as against Rs 512.81 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 126.99 | 118.49 | 7 | 582.05 | 512.81 | 14 |
| OPM % | 16.32 | 13.43 | - | 22.02 | 20.02 | - |
| PBDT | 22.23 | 17.70 | 26 | 134.91 | 107.18 | 26 |
| PBT | 17.74 | 13.81 | 28 | 117.84 | 91.68 | 29 |
| NP | 13.24 | 10.35 | 28 | 87.66 | 67.64 | 30 |